Related Experiment Video
Updated: Jan 28, 2026

Mouse Model of Pressure Ulcers After Spinal Cord Injury
Published on: March 9, 2019
Over-the-scope-clip applications for perforated peptic ulcer
Jing-Jing Wei1, Xue-Ping Xie1, Ting-Ting Lian1
1Endoscopic Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
Over-the-scope-clip (OTSC) endoscopic closure is effective for perforated peptic ulcers (PPU). This minimally invasive technique offers high success rates and faster oral feeding resumption compared to conservative treatments.
Area of Science:
- Gastroenterology
- Endoscopic Surgery
- Surgical Innovation
Background:
- Perforated peptic ulcer (PPU) is a serious condition requiring prompt management.
- Traditional treatments for PPU can involve significant morbidity and mortality.
- Endoscopic interventions offer a less invasive alternative for managing gastrointestinal defects.
Purpose of the Study:
- To evaluate the efficacy of over-the-scope-clip (OTSC) endoscopic closure for treating perforated peptic ulcers (PPU).
- To compare OTSC closure outcomes against conservative management strategies in PPU patients.
Main Methods:
- A comparative study involving 106 patients diagnosed with PPU.
- Patients were treated with either OTSC (n=26) or conservative methods (n=80).
- Outcomes assessed included technical and clinical success, complications, mortality, time to oral feeding, hospital stay, and antibiotic use.
Main Results:
- OTSC achieved 100% technical and clinical success with no complications or mortality.
- Patients treated with OTSC resumed oral feeding significantly faster (median 3.5 days vs. 7.0 days).
- No additional surgeries were required for OTSC patients, unlike 30% in the conservative group.
Conclusions:
- OTSC-based endoscopic closure is a highly effective treatment for PPU, particularly for defects <15 mm.
- The technique demonstrates a high clinical success rate and leads to quicker patient recovery and oral feeding resumption.
- OTSC offers a safe and efficient alternative to conventional treatments for select PPU cases.
Related Concept Videos
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...

